Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis? - Wikidata - thesis-toulmin - TriplyDB

Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?

Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?

http://www.wikidata.org/entity/Q26766689

about

Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study Overexpression of Yes-associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta-analysis.Emerging tyrosine kinase inhibitors for the treatment of hepatocellular carcinoma.Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic review.The status of transarterial chemoembolization treatment in the era of precision oncology.Radiosensitization by Marine Sponge Agelas sp. Extracts in Hepatocellular Carcinoma Cells with Autophagy Induction.

P2860

Q26741201-E33D26BC-5E45-49C6-BC07-8B4A593856BD Q28079205-B2962F8A-5D8E-45CA-BCC1-BF624A1028FC Q33441170-DF59062C-6E03-4B3A-999B-AB365B2CA77F Q38371893-A756E35E-D021-4B87-8B52-205EA7EAC5E4 Q39366121-9BD70DB1-81AD-46D2-8B23-0FEE5B550CAF Q41092750-F4A03382-BAEC-42BC-A6C7-DDE1175F1B93 Q46024539-98561C5E-7D66-41E1-ABC0-628F3048FE45 Q49491370-1B489AF5-987E-4AF0-89F8-C4CEDA35665F Q54940323-356972F1-A369-4FC2-BDC7-80355488CACB

P2860

Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?

http://www.wikidata.org/entity/Q26766689

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Molecularly targeted therapy f ...... a - a drug development crisis?

@ast

Molecularly targeted therapy f ...... a - a drug development crisis?

@en

Molecularly targeted therapy f ...... a - a drug development crisis?

@nl

type

label

Molecularly targeted therapy f ...... a - a drug development crisis?

@ast

Molecularly targeted therapy f ...... a - a drug development crisis?

@en

Molecularly targeted therapy f ...... a - a drug development crisis?

@nl

prefLabel

Molecularly targeted therapy f ...... a - a drug development crisis?

@ast

Molecularly targeted therapy f ...... a - a drug development crisis?

@en

Molecularly targeted therapy f ...... a - a drug development crisis?

@nl

P1433

Q26766689-5D8FA36F-35E3-4ABE-967C-E9C9197746EF

P1476

Q26766689-5A2DFA73-26DD-499D-8EAF-765FD4B1F308

P2093

Q26766689-94B3B95C-5C9D-44C9-A401-08674BFB4DAA

P2860

Q26766689-002ED298-01EB-42AD-A4C0-B957837A4B91

Q26766689-00C66072-7C1E-477A-BC8C-4D967A117B4A

Q26766689-01EDB236-CB33-42D2-A559-9C2C55AD21E4

Q26766689-0EDB3B7C-2306-41FE-B068-F6F725E82AEF

Q26766689-109A953C-1CDF-4508-BCE5-DB8422581B88

Q26766689-10A9DA84-36C2-40D8-BB15-A548D47E4CB9

Q26766689-1195020F-EF17-4060-9EF9-D6D9EA724E51

Q26766689-15EDCC6A-DA08-48F3-9BFD-8405EBAC98F4

Q26766689-1855B808-A68C-4AE9-A34E-04237164DA06

Q26766689-25E0C193-09ED-485C-9F8F-06BA78781CA9

P304

Q26766689-58F07C0E-ED64-43AD-A43E-98D004C5CFCC

P31

Q26766689-4A0E4121-5751-485A-87D8-1B98C7D7B697

P356

Q26766689-5400BD12-9BE2-4C0A-B52F-4CA0E374754E

P407

Q26766689-BCEE8684-4758-4C27-A4CD-0DCE8EEBEB59

P433

Q26766689-AABAE356-EA28-4A6C-822C-99A4B95CEB85

P478

Q26766689-C7EFC47D-C142-43B8-9C27-DC19E413CD4A

P50

Q26766689-509DAB85-5405-420B-BFCE-BDE8A169B56E

Q26766689-CC2ABBD4-BCDB-426F-9E0E-3520E4805939

P577

Q26766689-6BC4293D-59F7-451E-ACF3-D94DB6A7A911

P5875

Q26766689-B64EC689-EA83-4E27-8E5E-C5DEB8E6D64E

P698

Q26766689-B6053316-FDD6-48EE-97E4-0A86E9847EC5

P932

Q26766689-0DCEE214-E3C6-4FD6-B13C-F525E07857EA

P356

P1433

World journal of gastrointestinal oncology

P1476

Molecularly targeted therapy f ...... a - a drug development crisis?

@en

P2093

Paul Ross

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma.

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Sorafenib in advanced hepatocellular carcinoma

P304

173-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4251/WJGO.V8.I2.173

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Kiruthikah Thillai

Debashis Sarker

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294421776

http://www.w3.org/2001/XMLSchema#string

P698

26909132

http://www.w3.org/2001/XMLSchema#string

P932

4753168

http://www.w3.org/2001/XMLSchema#string